Director, Minimally Invasive Surgery and Robotics, Chesapeake Urology
Director, Prostate Cancer Care Program, Chesapeake Urology
President, AUA, MidAtlantic Region
Past President, Baltimore City Medical Society
Background
Dr. Lowentritt has a general urology practice with a focus on minimally invasive techniques to treat urological conditions. His expertise includes robotic, laparoscopic, and endoscopic management of renal, bladder, and prostate cancer, as well as minimally invasive options for benign prostatic hyperplasia (BPH), kidney stones, pelvic organ prolapse, and ureteropelvic junction obstruction.
Dr. Lowentritt has been at the forefront of robotic urology procedures and was the first surgeon in Maryland to perform robot assisted surgery for bladder cancer.
He has authored numerous articles and chapters on subjects including robotic surgery, erectile dysfunction, pediatric urology, female urology and the urological management of patients after renal transplantation.
Dr. Lowentritt has been selected as a “Super Doctor” by his peers in The Washington Post magazine and as a “Top Doctor” in Baltimore magazine numerous times. Dr. Lowentritt serves on the Board of Directors for the Baltimore City Medical Society and is President of the AUA, Mid-Atlantic Region.

Specialties
- 3D Ultrasound/MRI Fusion Prostate Cancer Biopsy
- Advanced Prostate Cancer Treatment
- Benign Prostatic Hyperplasia/BPH
- General Urology
- High-Intensity Focused Ultrasound (HIFU)
- Kidney Stones
- Laparoscopic & Robotic Surgery
- Minimally Invasive Prostate Surgery
- Prostate Cancer
- Robotic surgery
- UroLift
Education and Achievements
Education
Honors & Awards
Certifications
Memberships
Office Locations
Towson
GBMC Campus/Physicians Pavilion North/Tulip Park, 6535 N. Charles Street, Suite 500, Towson, MD 21204, United StatesContact Us
Appointments & Information
*If this is an emergency, please call 911 immediately.
Please provide your email address and phone number and a Chesapeake Urology representative will contact you shortly to assist with your question or issue.
Monday–Friday, 8:30 a.m. to 4:30 p.m.